A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/1993
12/09/1993	CA2136428A1 Peptide inhibitors of selectin binding
12/08/1993	EP0572553A1 Recombinant thrombin receptor and related pharmaceuticals
12/08/1993	EP0572470A1 Process for producing a medical composition with a bone marrow protective effect and an anti-neoplastic effect
12/08/1993	EP0572449A1 (amidomethyl)nitrogen heterocyclic analgesics
12/08/1993	CN1079219A Arylacetamides
12/08/1993	CN1023013C Process for preparing thianaphthene derivatives
12/07/1993	US5268366 Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient
12/06/1993	CA2097766A1 Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides
12/01/1993	EP0571795A1 Novel 3-phenyl-1,2,5-oxadiazoles and their use in the treatment of cardiovascular disorders, in particular angina pectoris and erectile dysfunction
12/01/1993	EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
12/01/1993	EP0571602A1 Dimer of molecular variant of apolipoprotein and processes for the production thereof
12/01/1993	EP0571474A1 Orthomolecular method of treating sickle cell disease
12/01/1993	EP0571462A1 Prostacycline and carbacycline derivatives as agents for treating feverish complaints
12/01/1993	EP0502171A4 Composition for inducing granulocyte production or b cell production in peripheral blood
12/01/1993	EP0487591B1 Anticoagulant protein
12/01/1993	CN1022917C Process for 2-amino-tetrahydro-isoquinoline derivatives
11/1993
11/30/1993	US5266591 Ethanolamine benzoate compounds
11/30/1993	US5266578 Lipoxygenase inhibitors
11/30/1993	CA2097258A1 Phenylfuroxans
11/25/1993	WO1993023403A1 NOVEL MERCAPTOACETYLAMIDO PYRIDAZO[1,2]PYRIDAZINE, PYRAZOLO[1,2]PYRIDAZINE, PYRIDAZO[1,2-a][1,2]DIAZEPINE AND PYRAZOLO[1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
11/25/1993	WO1993023397A1 4-mercaptoacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
11/25/1993	WO1993023391A1 Substituted indoles and azaindoles as angiotensin ii antagonists
11/25/1993	WO1993023074A1 TRUNCATED TISSUE FACTOR AND FVIIa OR FVII ACTIVATOR FOR BLOOD COAGULATION
11/25/1993	WO1993023059A1 Use of exogeneous glycosaminoglycanes or derivatives in the treatment of thrombopenias
11/25/1993	WO1993017684A3 Enantiomeric hydroxylated xanthine compounds
11/25/1993	DE4216829A1 Pyridyl derivs. with antithrombotic properties
11/25/1993	DE4216364A1 Pyridyl derivs. with antithrombotic properties
11/25/1993	CA2135605A1 Substituted indoles and azaindoles as angiotensin ii antagonists
11/24/1993	EP0571253A1 Benzimidazole derivatives with antidiabetic and antiplatelet aggregation activity
11/24/1993	EP0570519A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
11/24/1993	EP0570507A1 Anti-aggregatory peptides containing an aromatic ester or amide
11/24/1993	EP0570428A1 FACTOR IIa INHIBITORS
11/24/1993	EP0570375A1 Novel peptides with anticoagulatory effect.
11/23/1993	US5264425 Glycosaminoglycan salts and pharmaceutical compositions containing them
11/23/1993	US5264209 Modified HIL-6
11/20/1993	CA2096475A1 Benzimidazole derivatives; process for their preparation and pharmaceutical compositions containing them
11/18/1993	EP0570263A1 New alkene carboxylic acid derivatives, process for their preparation and pharmaceutic compositions containing them
11/18/1993	EP0569802A1 Arylacetamides
11/18/1993	EP0569479A1 Long-term delivery device including hydrophobic loading dose
11/18/1993	EP0362272B1 Method and compositions for making acsf and acsf antagonists
11/17/1993	CN1078469A Substituted indole, azaindole and tetrahydro-1H-pyrrol pyrrolo \|2,3-c¨ pyridin-7-one derivatives
11/17/1993	CN1078401A Immunotoxins directed against CD33 related surface antigens
11/16/1993	US5262426 Treatment of cardiovascular disorders, antiinflammatory agents
11/16/1993	US5262425 α-mannosidase inhibitors
11/16/1993	US5262325 Using heparinase free of anticoagulants
11/15/1993	CA2095404A1 Purification and characterization of a csvtcg-specific tumor cell adhesion receptor
11/11/1993	WO1993022447A1 Novel polypeptide
11/11/1993	WO1993022437A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
11/11/1993	WO1993022340A1 Modulation of thrombospondin-cd36 interactions
11/11/1993	WO1993022335A1 Stable polypeptide composition
11/11/1993	WO1993022309A1 4-imidomethyl-1-[2'phenyl-2'oxoethyl-] piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy
11/11/1993	WO1993022303A1 1-piperazineacetic derivatives as fibrinogen receptor antagonists
11/11/1993	WO1993021956A1 Antibodies to p-selectin and their uses
11/11/1993	WO1993021940A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
11/11/1993	WO1993021936A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
11/11/1993	WO1993021933A1 Safe human transfusion blood
11/11/1993	CA2134655A1 Modulation of thrombospondin-cd36 interactions
11/11/1993	CA2133580A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
11/10/1993	EP0569337A1 Heteroatoms-containing tricyclic compounds
11/10/1993	EP0568833A1 Human antithrombin III mutants
11/09/1993	US5260307 Guanidine derivatives compositions and use
11/09/1993	US5260274 Factor VIII binding domain of von Willebrand Factor
11/09/1993	US5260224 Tissue injury prevention
11/09/1993	US5259951 Passing solution of Factor VIII from human plasma through ion exchange chromatographic column using as equilibrating buffer and eluent high ionic strength saline solution at acid pH; stabilizers
11/09/1993	CA1324140C 2-phenyl-3-acylaminomethyl-5,6,7,8-tetrahydroimidazo [1,2-a]pyridine derivatives
11/03/1993	EP0568306A1 Anticonvulsant fructopyranose cyclic sulfites and sulfates
11/03/1993	EP0567968A1 Cyclic imino derivatives, medicaments containing these compounds and processes for the production thereof
11/03/1993	EP0567966A1 Cyclic imino derivatives, medicaments containing these compounds and processes for the production thereof
11/03/1993	EP0567599A1 Megakaryocyte stimulating factors
11/03/1993	EP0551286A4 Soluble hirudin conjugates
11/03/1993	EP0450041B1 Orally administered porphyrins to control intestinal iron absorption
11/03/1993	EP0374182B1 Biospecific polymers
11/03/1993	EP0357788B1 Pyridazinone derivatives
11/03/1993	CN1077961A Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds
11/03/1993	CN1077960A Hemoregulatory peptides
11/03/1993	CN1077958A Triazolopyridazine compounds, their production and use
11/03/1993	CN1077953A 乙酸衍生物 Acetic acid derivatives
10/1993
10/29/1993	CA2095009A1 Cyclic imino derivatives
10/29/1993	CA2094964A1 Cyclic imino derivatives
10/28/1993	WO1993021328A1 Polypeptides having kinase activity, their preparation and use
10/28/1993	WO1993021229A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects
10/28/1993	WO1993021214A1 Alpha-aminoboronic acid peptides and their use as elastase inhibitors
10/28/1993	WO1993021213A1 Alpha-aminoboronic acid peptides and their use as elastase inhibitors
10/28/1993	WO1993021212A1 Lactam dipeptides having hle inhibiting activity
10/28/1993	WO1993021210A1 Pyrimidinyl acetamides as elastase inhibitors
10/28/1993	WO1993021209A1 Lactam peptides having hle inhibiting activity
10/28/1993	WO1993020848A1 Immunotoxins directed against cd33 related surface antigens
10/28/1993	WO1993019089A3 Oxygen carrier
10/28/1993	WO1993009222A3 Transfection of vertebrate cells e.g. by homologous recombination
10/28/1993	CA2133659A1 Pyrimidinyl acetamides as elastase inhibitors
10/28/1993	CA2133658A1 Heterocyclic derivatives
10/28/1993	CA2133657A1 Substituted derivatives
10/28/1993	CA2132543A1 Lactam dipeptides having hle inhibiting activity
10/28/1993	CA2118250A1 Lactam peptides having hle inhibiting activity
10/27/1993	EP0567448A1 Factor VIII preparation
10/27/1993	EP0566919A1 2,4-dioxoimidazoline derivatives
10/27/1993	EP0566732A1 Adeno-associated virus-2 basal vectors
10/27/1993	CN1022566C Process for preparation of substituted 1-piperidylalkylene-pyridopyrimidone or thiazolpyrimidone
10/26/1993	US5256770 Oxidation resistant thrombomodulin analogs
10/26/1993	US5256642 Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof

1 ... 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 ... 671